From: An assessment of canine ectoparasiticide administration compliance in the USA
Product | Six-month dosing period including average gap duration (weeks) | Percentage of period protected |
---|---|---|
Fluralaner 12-week dosing | 36.8 | 65 |
Fluralaner 8-week dosing | 58.1 | 55 |
Afoxolaner | 71.4 | 36 |
Sarolaner | 103.6 | 25 |
Lotilaner | 56.0 | 46 |